Table 3.
Incidences of HBV reactivation based on HBsAg status and antiviral prophylaxis.
| Total, n | HBV reactivation, n (%) | |
|---|---|---|
| HBsAg-positive patients | 189 | 14 (7.4) |
| HBsAg-negative and HBcAb-positive patients | 24 | 2 (8.3) |
| No antiviral prophylaxis | 32 | 7 (21.9) |
| Undetectable baseline HBV DNA | 25 | 7 (28) |
| Detectable baseline HBV DNA | 7 | 0 |
| Antiviral prophylaxis | 181 | 9 (5) |
| Undetectable baseline HBV DNA | 42 | 5 (11.9) |
| Detectable baseline HBV DNA | 139 | 4 (2.9) |
HBV, hepatitis B virus; HBsAg, hepatitis B surface antigen; HBcAb, hepatitis B core antibody; DNA, deoxyribonucleic acid.